Coronary Artery Aneurysm After Drug-Eluting Stent Implantation Causing Coronary-Bronchial Fistula

Coronary artery aneurysm (CAA) after drug-eluting stent implantation is rare, with a reported incidence of 0.3% to 6.0%. Most of these aneurysms are asymptomatic. Hemoptysis as a presentation of CAA is very rare. The patient in our case had CAA after zotarolimus-eluting stent implantation and presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Ankush, Datta, Rajat, Chhikara, Sanya, Dhagat, Peeyush K., Vijayvergiya, Rajesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Mini-Focus Issue: Coronaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312138/
https://www.ncbi.nlm.nih.gov/pubmed/34317036
http://dx.doi.org/10.1016/j.jaccas.2020.07.041
Descripción
Sumario:Coronary artery aneurysm (CAA) after drug-eluting stent implantation is rare, with a reported incidence of 0.3% to 6.0%. Most of these aneurysms are asymptomatic. Hemoptysis as a presentation of CAA is very rare. The patient in our case had CAA after zotarolimus-eluting stent implantation and presented with hemoptysis resulting from a leaking coronary-bronchial fistula. (Level of Difficulty: Intermediate.)

Ejemplares similares